Zhong Yuan Bio-Technology Holdings Limited
ZHYBF
$2.02
$1.891,468.32%
OTC PK
06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
---|---|---|---|---|---|
Revenue | 323.48% | -- | -- | -19.67% | -44.37% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 323.48% | -- | -- | -19.67% | -44.37% |
Cost of Revenue | 274.86% | -- | -- | 154.55% | -85.15% |
Gross Profit | 326.99% | -- | -- | -82.23% | -29.72% |
SG&A Expenses | -17.34% | -- | -- | 1.63% | -24.32% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 32.45% | -- | -- | 38.65% | -14.78% |
Operating Income | 247.79% | -- | -- | -214.98% | -74.64% |
Income Before Tax | 241.11% | -- | -- | -638.62% | -165.27% |
Income Tax Expenses | 92.11% | -- | -- | -325.00% | -480.00% |
Earnings from Continuing Operations | 245.38% | -- | -- | -620.23% | -152.96% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 123.21% | -- | -- | -- | -- |
Net Income | 253.39% | -- | -- | -605.15% | -147.52% |
EBIT | 247.79% | -- | -- | -214.98% | -74.64% |
EBITDA | 248.84% | -- | -- | -217.35% | -75.64% |
EPS Basic | 253.06% | 19.67% | 20.11% | -586.89% | -140.98% |
Normalized Basic EPS | 253.76% | -- | -- | -340.54% | -151.35% |
EPS Diluted | 250.34% | 19.67% | 20.11% | -586.89% | -140.98% |
Normalized Diluted EPS | 251.61% | -- | -- | -340.54% | -151.35% |
Average Basic Shares Outstanding | 0.31% | 2.21% | -- | 2.96% | 2.80% |
Average Diluted Shares Outstanding | 2.01% | 2.21% | 2.25% | 2.96% | 2.80% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |